Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Cerundolo V

Collect these papers and discover other ones on Labmeeting. Learn more.

Quantitating T cell cross-reactivity for unrelated Peptide antigens.

+ cite this

+ View Abstract

Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, Wang L, Dong T, Pasquetto V, Oseroff C, Sidney J, Hickman H, Cerundolo V, Sette A, Bennink JR, McMichael A,

(show remaining authors)

Journal of immunology (Baltimore, Md. : 1950) 183(7):4337-45, 2009 Oct 1 - Who cited this? | PubMed ID: 19734234 | Fulltext

Linking inflammation to natural killer T cell activation.

+ cite this

+ View Abstract

Salio M and Cerundolo V

PLoS biology 7(10):e1000226, 2009 Oct - Who cited this? | PubMed ID: 19859527 | Fulltext

Aberrant selection and function of invariant NKT cells in the absence of AP-1 transcription factor Fra-2.

+ cite this

+ View Abstract

Lawson VJ, Maurice D, Silk JD, Cerundolo V, and Weston K

Journal of immunology (Baltimore, Md. : 1950) 183(4):2575-84, 2009 Aug 15 - Who cited this? | PubMed ID: 19620306 | Fulltext

Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.

+ cite this

+ View Abstract

Veerapen N, Brigl M, Garg S, Cerundolo V, Cox LR, Brenner MB, and Besra GS

Bioorganic & medicinal chemistry letters 19(15):4288-91, 2009 Aug 1 - Who cited this? | PubMed ID: 19502056 | Fulltext

T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.

+ cite this

+ View Abstract

Mallevaey T, Scott-Browne JP, Matsuda JL, Young MH, Pellicci DG, Patel O, Thakur M, Kjer-Nielsen L, Richardson SK, Cerundolo V, Howell AR, McCluskey J, Godfrey DI, Rossjohn J, Marrack P, and Gapin L

Immunity 31(1):60-71, 2009 Jul 17 - Who cited this? | PubMed ID: 19592274 | Fulltext

A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.

+ cite this

+ View Abstract

Palmowski MJ, Parker M, Choudhuri K, Chiu C, Callan MF, van der Merwe PA, Cerundolo V, and Gould KG

Journal of immunology (Baltimore, Md. : 1950) 182(8):4565-71, 2009 Apr 15 - Who cited this? | PubMed ID: 19342630 | Fulltext

Rational development of high-affinity T-cell receptor-like antibodies.

+ cite this

+ View Abstract

Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, Fischer E, Kleber S, Stenner-Liewen F, Bauer S, McMichael A, Knuth A, Abken H, Hombach AA, Cerundolo V, Jones EY, and Renner C

Proceedings of the National Academy of Sciences of the United States of America 106(14):5784-8, 2009 Apr 7 - Who cited this? | PubMed ID: 19307587 | Fulltext

Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.

+ cite this

+ View Abstract

Reddy BG, Silk JD, Salio M, Balamurugan R, Shepherd D, Ritter G, Cerundolo V, and Schmidt RR

ChemMedChem 4(2):171-5, 2009 Feb - Who cited this? | PubMed ID: 19160440 | Fulltext

Analysis of frequency and phenotype of antigen-specific T cells.

+ cite this

+ View Abstract

Stock A and Cerundolo V

Methods in molecular biology (Clifton, N.J.) 514:1-14, 2009 - Who cited this? | PubMed ID: 19048209 | Fulltext

Harnessing invariant NKT cells in vaccination strategies.

+ cite this

+ View Abstract

Cerundolo V, Silk JD, Masri SH, and Salio M

Nature reviews. Immunology 9(1):28-38, 2009 Jan - Who cited this? | PubMed ID: 19079136 | Fulltext

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.

+ cite this

+ View Abstract

De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, Gröne HJ, Platt FM, Zambon M, and Cerundolo V

The Journal of clinical investigation 118(12):4036-48, 2008 Dec - Who cited this? | PubMed ID: 19033672 | Fulltext

Structural and Functional Aspects of Lipid Binding by CD1 Molecules.

+ cite this

+ View Abstract

Silk JD, Salio M, Brown J, Jones EY, and Cerundolo V

Annual review of cell and developmental biology 24:369-395, 2008 Nov 10 - Who cited this? | PubMed ID: 18593354 | Fulltext

CD1d presentation of glycolipids.

+ cite this

+ View Abstract

Speak AO, Cerundolo V, and Platt FM

Immunology and cell biology 86(7):588-97, 2008 Oct - Who cited this? | PubMed ID: 18542099 | Fulltext

[Glycosphingolipids Gb3 and iGb3 : In vivo roles in hemolytic-uremic syndrome and iNKT cell function.].

+ cite this

+ View Abstract

Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, and Gröne HJ

Der Pathologe, 2008 Aug 31 - Who cited this? | PubMed ID: 18810447 | Fulltext

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.

+ cite this

+ View Abstract

Barral P, Eckl-Dorna J, Harwood NE, De Santo C, Salio M, Illarionov P, Besra GS, Cerundolo V, and Batista FD

Proceedings of the National Academy of Sciences of the United States of America 105(24):8345, 2008 Jun 17 - Who cited this? | PubMed ID: 18550831 | Fulltext

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.

+ cite this

+ View Abstract

Silk JD, Salio M, Reddy BG, Shepherd D, Gileadi U, Brown J, Masri SH, Polzella P, Ritter G, Besra GS, Jones EY, Schmidt RR, and Cerundolo V

Journal of immunology (Baltimore, Md. : 1950) 180(10):6452, 2008 May 15 - Who cited this? | PubMed ID: 18453560 | Fulltext

Correction: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

+ cite this

Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, and Renner C

European journal of immunology 38(5):1465-6, 2008 May - Who cited this? | PubMed ID: 18425731 | Fulltext

Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.

+ cite this

+ View Abstract

Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, and Reiter Y

European journal of immunology 38(3):829, 2008 Mar - Who cited this? | PubMed ID: 18253930 | Fulltext

Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.

+ cite this

+ View Abstract

Barnes E, Salio M, Cerundolo V, Francesco L, Pardoll D, Klenerman P, and Cox A

Journal of viral hepatitis 15(3):219-28, 2008 Mar - Who cited this? | PubMed ID: 18194173 | Fulltext

Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.

+ cite this

+ View Abstract

Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, and Lehner PJ

Proceedings of the National Academy of Sciences of the United States of America 105(5):1656, 2008 Feb 5 - Who cited this? | PubMed ID: 18230726 | Fulltext

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.

+ cite this

+ View Abstract

Lopes L, Dewannieux M, Gileadi U, Bailey R, Ikeda Y, Whittaker C, Collin MP, Cerundolo V, Tomihari M, Ariizumi K, and Collins MK

Journal of virology 82(1):86-95, 2008 Jan - Who cited this? | PubMed ID: 17959670 | Fulltext

Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.

+ cite this

+ View Abstract

Salio M, Speak AO, Shepherd D, Polzella P, Illarionov PA, Veerapen N, Besra GS, Platt FM, and Cerundolo V

Proceedings of the National Academy of Sciences of the United States of America 104(51):20490-5, 2007 Dec 18 - Who cited this? | PubMed ID: 18077358 | Fulltext

Structures of an MHC class I molecule from b21 chickens illustrate promiscuous Peptide binding.

+ cite this

+ View Abstract

Koch M, Camp S, Collen T, Avila D, Salomonsen J, Wallny HJ, van Hateren A, Hunt L, Jacob JP, Johnston F, Marston DA, Shaw I, Dunbar PR, Cerundolo V, Jones EY, and Kaufman J

Immunity 27(6):885-99, 2007 Dec - Who cited this? | PubMed ID: 18083574 | Fulltext

Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses.

+ cite this

+ View Abstract

Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, Cerundolo V, and Ronchese F

Journal of immunology (Baltimore, Md. : 1950) 179(9):5738-47, 2007 Nov 1 - Who cited this? | PubMed ID: 17947646 | Fulltext

T cell receptors get back to basics.

+ cite this

Jones EY, Salio M, and Cerundolo V

Nature immunology 8(10):1033-5, 2007 Oct - Who cited this? | PubMed ID: 17878911 | Fulltext

A closer look at CD1d molecules: new horizons in studying NKT cells.

+ cite this

+ View Abstract

Stronge VS, Salio M, Jones EY, and Cerundolo V

Trends in immunology 28(10):455-62, 2007 Oct - Who cited this? | PubMed ID: 17825624 | Fulltext

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

+ cite this

+ View Abstract

Held G, Wadle A, Dauth N, Stewart-Jones G, Sturm C, Thiel M, Zwick C, Dieckmann D, Schuler G, Hoogenboom HR, Lévy F, Cerundolo V, Pfreundschuh M, and Renner C

European journal of immunology 37(7):2008-17, 2007 Jul - Who cited this? | PubMed ID: 17559180 | Fulltext

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.

+ cite this

+ View Abstract

McCarthy C, Shepherd D, Fleire S, Stronge VS, Koch M, Illarionov PA, Bossi G, Salio M, Denkberg G, Reddington F, Tarlton A, Reddy BG, Schmidt RR, Reiter Y, Griffiths GM, van der Merwe PA,

(show remaining authors)

The Journal of experimental medicine 204(5):1131-44, 2007 May 14 - Who cited this? | PubMed ID: 17485514 | Fulltext

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

+ cite this

+ View Abstract

Wooldridge L, Lissina A, Vernazza J, Gostick E, Laugel B, Hutchinson SL, Mirza F, Dunbar PR, Boulter JM, Glick M, Cerundolo V, van den Berg HA, Price DA, and Sewell AK

European journal of immunology 37(5):1323-33, 2007 May - Who cited this? | PubMed ID: 17429845 | Fulltext

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

+ cite this

+ View Abstract

Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, and Gröne HJ

Proceedings of the National Academy of Sciences of the United States of America 104(14):5977-82, 2007 Apr 3 - Who cited this? | PubMed ID: 17372206 | Fulltext

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.

+ cite this

+ View Abstract

Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, Platt N, Heare T, Butters TD, Dwek RA, Trottein F, Exley MA, Cerundolo V, and Platt FM

Proceedings of the National Academy of Sciences of the United States of America 104(14):5971-6, 2007 Apr 3 - Who cited this? | PubMed ID: 17372214 | Fulltext

Modulation of CD103 expression on human colon carcinoma-specific CTL.

+ cite this

+ View Abstract

Ling KL, Dulphy N, Bahl P, Salio M, Maskell K, Piris J, Warren BF, George BD, Mortensen NJ, and Cerundolo V

Journal of immunology (Baltimore, Md. : 1950) 178(5):2908, 2007 Mar 1 - Who cited this? | PubMed ID: 17312135 | Fulltext

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.

+ cite this

+ View Abstract

Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, and Cerundolo V

Journal of immunology (Baltimore, Md. : 1950) 178(5):2721-9, 2007 Mar 1 - Who cited this? | PubMed ID: 17312114 | Fulltext

Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo.

+ cite this

+ View Abstract

Chiu C, Heaps AG, Cerundolo V, McMichael AJ, Bangham CR, and Callan MF

Blood 109(3):1086-94, 2007 Feb 1 - Who cited this? | PubMed ID: 16990607 | Fulltext

Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

+ cite this

+ View Abstract

Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, Banham AH, and Cerundolo V

Cancer immunity : a journal of the Academy of Cancer Immunology 7:7, 2007 - Who cited this? | PubMed ID: 17388261 | Fulltext

Harnessing NKT cells for therapeutic applications.

+ cite this

+ View Abstract

Cerundolo V and Salio M

Current topics in microbiology and immunology 314:325-40, 2007 - Who cited this? | PubMed ID: 17593667 | Fulltext

Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection.

+ cite this

+ View Abstract

Mosley AJ, Meekings KN, McCarthy C, Shepherd D, Cerundolo V, Mazitschek R, Tanaka Y, Taylor GP, and Bangham CR

Blood 108(12):3801, 2006 Dec 1 - Who cited this? | PubMed ID: 16912225 | Fulltext

Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.

+ cite this

+ View Abstract

Cerundolo V and de la Salle H

Seminars in immunology 18(6):330-6, 2006 Dec - Who cited this? | PubMed ID: 16973375 | Fulltext

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

+ cite this

+ View Abstract

Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, Besra GS, Dwek R, Butters TD, Platt FM, and Cerundolo V

The Journal of experimental medicine 203(10):2293-303, 2006 Oct 2 - Who cited this? | PubMed ID: 16982810 | Fulltext

Role of immunoproteasomes in cross-presentation.

+ cite this

+ View Abstract

Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E, Addey C, Scott D, Dyson J, Simpson E, and Cerundolo V

Journal of immunology (Baltimore, Md. : 1950) 177(2):983-90, 2006 Jul 15 - Who cited this? | PubMed ID: 16818754 | Fulltext

Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.

+ cite this

+ View Abstract

Purbhoo MA, Sutton DH, Brewer JE, Mullings RE, Hill ME, Mahon TM, Karbach J, Jäger E, Cameron BJ, Lissin N, Vyas P, Chen JL, Cerundolo V, and Jakobsen BK

Journal of immunology (Baltimore, Md. : 1950) 176(12):7308-16, 2006 Jun 15 - Who cited this? | PubMed ID: 16751374 | Fulltext

Malignant melanoma and bone resorption.

+ cite this

+ View Abstract

Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, and Athanasou NA

British journal of cancer 94(10):1496-503, 2006 May 22 - Who cited this? | PubMed ID: 16641914 | Fulltext

Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

+ cite this

+ View Abstract

Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, Cerundolo V, and Crocker PR

Blood 107(9):3600, 2006 May 1 - Who cited this? | PubMed ID: 16397130 | Fulltext

Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.

+ cite this

+ View Abstract

Quiroga I, Salio M, Koo DD, Cerundolo L, Shepherd D, Cerundolo V, and Fuggle SV

Transplantation 81(8):1196-203, 2006 Apr 27 - Who cited this? | PubMed ID: 16641608 | Fulltext

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.

+ cite this

+ View Abstract

Kotsianidis I, Silk JD, Spanoudakis E, Patterson S, Almeida A, Schmidt RR, Tsatalas C, Bourikas G, Cerundolo V, Roberts IA, and Karadimitris A

Blood 107(8):3138, 2006 Apr 15 - Who cited this? | PubMed ID: 16373666 | Fulltext

Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.

+ cite this

+ View Abstract

Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, Matulis G, Harlos K, Villiger PM, Stuart DI, Jakobsen BK, Cerundolo V, and Jones EY

The Journal of experimental medicine 203(3):699-710, 2006 Mar 20 - Who cited this? | PubMed ID: 16520393 | Fulltext

B and CTL responses to the ALK protein in patients with ALK-positive ALCL.

+ cite this

+ View Abstract

Ait-Tahar K, Cerundolo V, Banham AH, Hatton C, Blanchard T, Kusec R, Becker M, Smith GL, and Pulford K

International journal of cancer. Journal international du cancer 118(3):688-95, 2006 Feb 1 - Who cited this? | PubMed ID: 16114011 | Fulltext

HIV-1 down-regulates the expression of CD1d via Nef.

+ cite this

+ View Abstract

Chen N, McCarthy C, Drakesmith H, Li D, Cerundolo V, McMichael AJ, Screaton GR, and Xu XN

European journal of immunology 36(2):278-86, 2006 Feb - Who cited this? | PubMed ID: 16385629 | Fulltext

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

+ cite this

+ View Abstract

Smith CL, Mirza F, Pasquetto V, Tscharke DC, Palmowski MJ, Dunbar PR, Sette A, Harris AL, and Cerundolo V

Journal of immunology (Baltimore, Md. : 1950) 175(12):8431-7, 2005 Dec 15 - Who cited this? | PubMed ID: 16339586 | Fulltext

Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.

+ cite this

+ View Abstract

Trautmann L, Rimbert M, Echasserieau K, Saulquin X, Neveu B, Dechanet J, Cerundolo V, and Bonneville M

Journal of immunology (Baltimore, Md. : 1950) 175(9):6123, 2005 Nov 1 - Who cited this? | PubMed ID: 16237109 | Fulltext

Search Google Scholar for Cerundolo V

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!